Lens ID,Title,Date Published,Publication Year,Publication Type,Source Title,ISSNs,Publisher,Source Country,Author/s,Abstract,Volume,Issue Number,Start Page,End Page,Fields of Study,Keywords,MeSH Terms,Chemicals,Funding,Source URLs,External URL,PMID,DOI,Microsoft Academic ID,PMCID,Citing Patents Count,References,Citing Works Count
000-141-187-087-774,Nanomaterials and Catalysis,,2011,book chapter,Nanostructured Materials for Engineering Applications,,Springer Berlin Heidelberg,,Annelise Kopp Alves; Felipe Amorim Berutti; Felipe Antonio Lucca Sánchez,"Catalysts are typical nanomaterials, perhaps the first nanomaterials in wide applications. Catalysis is a nanoscale phenomenon that has been the subject of research and development for many years, but only recently has it become a nanoscale science of materials and chemistry involving more investigations on the molecular level. Nanomaterial-based catalysts are usually heterogeneous catalysts. The extremely small size of the particles maximizes surface area exposed to the reactant, allowing more reactions to occur. However, thermal stability of these nanomaterials is limited by their critical sizes; the smaller the crystallite size, the lower the thermal stability. In this chapter the characterization of metal oxides such as CeO2, TiO2, and ZnO and some of their applications as catalysts for methane combustion and photocatalysis is described. The effects of mixed oxides, and mixed phases were investigated.",,,93,117,Crystallite; Nanomaterials; Catalysis; Nanotechnology; Materials science; Catalytic combustion; Characterization (materials science); Nanoscopic scale; Thermal stability; Photocatalysis,,,,,https://rd.springer.com/chapter/10.1007%2F978-3-642-19131-2_7 https://link.springer.com/chapter/10.1007%2F978-3-642-19131-2_7 https://link.springer.com/10.1007/978-3-642-19131-2_7,http://dx.doi.org/10.1007/978-3-642-19131-2_7,,10.1007/978-3-642-19131-2_7,176833334,,0,004-309-913-732-603; 005-643-488-453-231; 007-615-568-063-633; 008-053-058-146-265; 008-587-901-342-873; 008-684-101-599-149; 009-291-359-109-61X; 010-094-466-520-327; 010-470-136-368-584; 011-823-106-894-433; 011-854-504-755-852; 012-656-754-069-627; 013-375-148-749-011; 015-049-031-343-64X; 018-232-090-111-376; 019-660-251-167-985; 019-735-413-819-389; 020-974-799-192-569; 027-180-271-177-280; 029-145-020-220-968; 030-743-042-893-00X; 032-382-361-753-540; 034-780-960-090-837; 037-063-567-284-202; 040-677-505-207-636; 042-346-158-659-502; 042-680-589-441-349; 044-035-949-106-378; 044-292-966-061-543; 050-576-091-808-115; 054-877-267-294-942; 056-891-164-714-098; 058-556-204-940-407; 058-574-777-415-553; 058-585-860-578-795; 059-429-344-440-046; 063-563-123-497-243; 065-125-287-882-802; 067-174-737-555-352; 073-511-680-113-183; 076-670-558-543-283; 080-248-822-554-629; 083-687-387-293-666; 087-453-497-478-462; 088-146-129-383-378; 090-499-078-516-593; 091-016-490-052-61X; 097-119-788-214-415; 098-474-204-886-254; 098-526-874-139-698; 100-919-525-336-180; 105-689-006-940-504; 105-848-345-402-167; 106-376-159-254-731; 111-845-214-178-285; 116-090-461-521-713; 116-487-754-115-458; 117-558-198-207-643; 119-217-858-275-084; 120-866-499-837-414; 132-947-069-286-114; 135-531-419-888-802; 136-170-642-130-258; 138-323-627-601-688; 138-506-147-508-777; 138-789-559-993-521; 140-564-411-117-554; 140-608-676-220-137; 141-861-471-230-089; 143-985-859-734-854; 150-665-205-549-220; 159-749-219-585-092; 161-086-248-475-084; 165-932-655-630-366; 171-094-169-886-89X; 173-537-190-765-374; 175-053-745-559-200; 177-531-502-478-111,3
000-329-230-459-620,Cellular Toxicity and Immunological Effects of Carbon-based Nanomaterials,4/11/2019,2019,journal article,Particle and fibre toxicology,17438977,BioMed Central,United Kingdom,Xia Yuan; Xiangxian Zhang; Lu Sun; Yuquan Wei; Xiawei Wei,"Carbon nanomaterials are a growing family of materials featuring unique physicochemical properties, and their widespread application is accompanied by increasing human exposure. Considerable efforts have been made to characterize the potential toxicity of carbon nanomaterials in vitro and in vivo. Many studies have reported various toxicology profiles of carbon nanomaterials. The different results of the cytotoxicity of the carbon-based materials might be related to the differences in the physicochemical properties or structures of carbon nanomaterials, types of target cells and methods of particle dispersion, etc. The reported cytotoxicity effects mainly included reactive oxygen species generation, DNA damage, lysosomal damage, mitochondrial dysfunction and eventual cell death via apoptosis or necrosis. Despite the cellular toxicity, the immunological effects of the carbon-based nanomaterials, such as the pulmonary macrophage activation and inflammation induced by carbon nanomaterials, have been thoroughly studied. The roles of carbon nanomaterials in activating different immune cells or inducing immunosuppression have also been addressed. Conclusion: Here, we provide a review of the latest research findings on the toxicological profiles of carbon-based nanomaterials, highlighting both the cellular toxicities and immunological effects of carbon nanomaterials. This review provides information on the overall status, trends, and research needs for toxicological studies of carbon nanomaterials.",16,1,1,27,Cytotoxicity; Nanomaterials; DNA damage; Chemistry; Toxicity; Carbon nanomaterials; Carbon based nanomaterials; Programmed cell death; Carbon; Biochemistry,Carbon nanomaterial; Cytotoxicity; Immunological effects; Macrophage,Animals; Apoptosis/drug effects; Carbon/chemistry; Cell Line; Cell Survival/drug effects; Cytokines/metabolism; Humans; Lung/drug effects; Lymphocytes/drug effects; Macrophages/drug effects; Nanostructures/chemistry; Particle Size; Surface Properties,Cytokines; Carbon,the National Natural Science Foundation of China; the National Key Research and Development Program of China,https://link.springer.com/article/10.1186/s12989-019-0299-z https://link.springer.com/content/pdf/10.1186/s12989-019-0299-z.pdf https://doaj.org/article/f5f0148c5ed342a6b3314ad79659a284 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460856 https://pubmed.ncbi.nlm.nih.gov/30975174/ https://particleandfibretoxicology.biomedcentral.com/articles/10.1186/s12989-019-0299-z,http://dx.doi.org/10.1186/s12989-019-0299-z,30975174,10.1186/s12989-019-0299-z,2945964100,PMC6460856,0,000-289-398-938-138; 000-304-942-202-275; 000-408-372-382-839; 000-458-326-685-260; 000-672-679-241-486; 000-722-339-723-983; 001-221-071-682-850; 001-783-499-024-36X; 002-380-466-060-639; 003-354-162-646-523; 004-089-528-905-713; 004-340-429-608-323; 005-054-807-897-409; 005-626-891-111-958; 005-716-268-121-272; 006-096-500-215-575; 006-695-429-395-319; 006-851-651-753-14X; 007-525-528-585-999; 008-026-084-779-329; 009-433-271-836-629; 009-456-342-310-432; 009-826-583-611-258; 009-839-349-649-592; 010-248-044-979-575; 010-937-918-890-314; 011-036-926-787-454; 011-181-272-451-257; 011-275-007-758-407; 011-344-587-439-539; 011-448-803-029-718; 011-789-629-199-839; 012-676-245-361-345; 012-749-102-372-172; 012-781-514-763-428; 012-858-381-884-543; 014-620-138-116-133; 014-851-110-178-090; 016-561-245-840-843; 016-573-632-276-638; 017-186-755-840-24X; 017-602-600-369-051; 018-173-008-558-455; 019-385-187-333-390; 020-058-618-038-199; 020-752-508-998-48X; 020-778-893-407-29X; 021-132-467-762-444; 021-442-133-926-115; 021-496-763-303-40X; 021-557-089-883-508; 021-832-527-337-587; 022-008-026-487-107; 022-089-937-878-931; 022-272-697-530-631; 022-631-097-994-290; 022-646-578-480-145; 024-391-762-181-074; 026-695-118-392-888; 027-414-420-907-638; 027-463-365-947-055; 028-470-973-284-111; 029-035-784-204-442; 029-217-416-387-158; 029-355-468-497-100; 029-485-059-651-328; 030-631-368-010-354; 030-779-488-554-12X; 031-410-368-468-346; 031-478-788-255-022; 032-146-888-430-567; 033-521-373-289-355; 034-591-735-254-900; 034-793-601-225-237; 035-476-252-570-143; 038-798-733-664-483; 038-855-488-498-255; 039-233-671-583-159; 041-300-455-745-140; 041-365-336-589-98X; 041-584-072-733-203; 042-232-815-071-78X; 042-870-359-465-561; 043-485-193-521-820; 043-939-849-770-963; 044-857-228-917-691; 044-865-466-893-672; 045-126-095-812-016; 046-153-688-474-390; 046-847-065-587-168; 047-479-487-714-788; 047-631-147-989-324; 048-784-224-431-919; 048-934-845-045-202; 049-295-741-481-120; 051-032-271-658-987; 051-126-598-938-187; 051-798-691-140-761; 051-859-802-611-076; 052-562-457-476-510; 052-964-239-218-347; 053-080-572-641-336; 053-837-387-381-271; 054-573-623-939-741; 055-165-874-363-170; 055-837-657-785-130; 055-921-408-762-204; 056-394-098-941-833; 056-490-194-990-846; 056-597-043-442-623; 057-198-716-894-105; 057-353-049-934-35X; 058-019-887-379-001; 058-640-350-311-643; 060-301-220-665-473; 060-789-141-965-584; 061-552-924-499-090; 062-322-849-180-911; 062-758-363-264-055; 063-088-966-764-792; 063-312-551-110-109; 064-634-172-146-353; 065-330-154-967-506; 069-553-181-408-009; 072-431-498-996-323; 072-485-598-734-519; 072-849-420-133-710; 073-260-146-068-286; 074-695-049-968-660; 074-718-901-171-93X; 074-728-644-019-708; 076-890-636-537-626; 080-110-418-364-856; 080-180-832-180-773; 081-114-288-967-601; 081-140-447-638-645; 082-512-666-548-499; 083-026-550-466-902; 083-340-158-269-483; 083-385-336-791-928; 083-880-928-070-233; 086-312-117-467-812; 087-159-044-329-07X; 088-398-258-633-258; 088-775-131-610-199; 089-423-508-333-636; 089-816-612-305-35X; 090-045-625-379-502; 090-188-337-776-675; 094-285-767-477-245; 095-363-742-021-054; 097-834-892-758-503; 098-302-321-478-451; 098-499-022-060-786; 099-565-449-408-373; 102-638-965-296-583; 103-994-259-809-115; 104-365-176-016-114; 106-426-894-716-608; 108-827-249-569-860; 111-010-950-042-639; 112-300-100-233-043; 113-599-541-422-398; 115-556-345-915-630; 120-682-080-240-276; 121-076-926-957-585; 121-125-992-064-425; 125-684-388-754-944; 127-515-001-286-847; 127-977-171-290-490; 128-225-825-099-535; 129-210-789-759-739; 130-934-131-000-821; 139-752-283-372-886; 142-923-615-918-315; 144-982-332-920-653; 145-202-591-485-656; 154-172-350-019-744; 176-183-131-995-966; 181-563-722-856-621; 183-576-808-283-743; 191-269-427-049-734; 193-616-090-773-482; 199-277-003-298-412,88
